| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 9 | |
| #2 | EPO (European Patent Office) | 8 | |
| #3 | Australia | 6 | |
| #4 | Japan | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 3 | |
| #6 | Canada | 2 | |
| #7 | China | 2 | |
| #8 | EAPO (Eurasian Patent Organization) | 1 | |
| #9 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Nuss John M | 11 |
| #2 | Xu Wei | 11 |
| #3 | Kim Moon Hwan | 11 |
| #4 | Wen Zhaoyang | 11 |
| #5 | Le Donna Tra | 10 |
| #6 | Bannen Lynne Canne | 10 |
| #7 | Rice Kenneth D | 9 |
| #8 | Mac Morrison B | 9 |
| #9 | Jammalamadaka Vasu | 9 |
| #10 | Mamo Shumeye | 9 |
| Publication | Filing date | Title |
|---|---|---|
| WO2014028334A1 | Selective mmp inhibitors | |
| EA025451B1 | Receptor-type kinase modulator and methods for treating polycystic kidney disease | |
| US2011082114A1 | Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors | |
| EP2277867A2 | Compounds, pharmaceutical compositions thereof and their use in treating cancer | |
| EP1511488A2 | Human adam-10 inhibitors |